SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/6EADD73BF0D4C2678881D6E27D80B61CA543E508651CE3643726F4838CFFE4E47D4BF2F86E83A9BCFBC56545B97BA1B9>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/6EADD73BF0D4C2678881D6E27D80B61CA543E508651CE3643726F4838CFFE4E47D4BF2F86E83A9BCFBC56545B97BA1B9
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/6EADD73BF0D4C2678881D6E27D80B61CA543E508651CE3643726F4838CFFE4E47D4BF2F86E83A9BCFBC56545B97BA1B9
http://www.w3.org/2000/01/rdf-schema#comment
"effect of activation following intranasal administration of peptide activator SLIGRL"
xsd:string
http://purl.uniprot.org/uniprot/#_B5C8B1A964C189AC8634E96B151FF4C6EFA6BDDE7D5C38DC55ACA35541070FA9BD38F78D1564D9F874AEC8F4F8090201
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/6EADD73BF0D4C2678881D6E27D80B61CA543E508651CE3643726F4838CFFE4E47D4BF2F86E83A9BCFBC56545B97BA1B9
http://purl.uniprot.org/uniprot/P55086
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6EADD73BF0D4C2678881D6E27D80B61CA543E508651CE3643726F4838CFFE4E47D4BF2F86E83A9BCFBC56545B97BA1B9
http://purl.uniprot.org/uniprot/#_P55086-mappedCitation-12034566
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6EADD73BF0D4C2678881D6E27D80B61CA543E508651CE3643726F4838CFFE4E47D4BF2F86E83A9BCFBC56545B97BA1B9